Literature DB >> 8230482

Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture.

O J Kim1, J L Yates.   

Abstract

We have isolated mutants of Epstein-Barr virus (EBV) which carry a dominant selectable marker inserted into the third exon of the gene encoding two membrane proteins, TP1 and TP2 (or LMP2A and LMP2B), which are expressed in latently infected, growth-transformed B cells. One of the mutants also acquired a 260-bp deletion beginning in the first intron a few base pairs from the terminal repeats and removing most of the second TP exon, including the initial coding sequences of TP2. These EBV mutants transform human B cells in culture, and the transformed B-cell clones carrying them release EBV at approximately normal frequencies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230482      PMCID: PMC238232     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences.

Authors:  S L Varmuza; J R Smiley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

2.  Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components.

Authors:  M F Stinski; T J Roehr
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

3.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

Authors:  D Wang; D Liebowitz; E Kieff
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

4.  Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus.

Authors:  V R Baichwal; B Sugden
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

Authors:  D Reisman; B Sugden
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA.

Authors:  T Matsuo; M Heller; L Petti; E O'Shiro; E Kieff
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

7.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

8.  Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA.

Authors:  L P Deiss; J Chou; N Frenkel
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

Review 9.  Transforming functions associated with Epstein-Barr virus.

Authors:  B Sugden; J Yates; W Mark
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

10.  Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation.

Authors:  S A Courtneidge
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  17 in total

Review 1.  Evolutionary aspects of oncogenic herpesviruses.

Authors:  J Nicholas
Journal:  Mol Pathol       Date:  2000-10

Review 2.  The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.

Authors:  H J Delecluse; W Hammerschmidt
Journal:  Mol Pathol       Date:  2000-10

3.  EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.

Authors:  Alexey V Gordadze; Chisaroka W Onunwor; RongSheng Peng; David Poston; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction.

Authors:  S Fruehling; S K Lee; R Herrold; B Frech; G Laux; E Kremmer; F A Grässer; R Longnecker
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.

Authors:  K L Fries; T B Sculley; J Webster-Cyriaque; P Rajadurai; R H Sadler; N Raab-Traub
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 6.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

7.  EBNA-LP associates with cellular proteins including DNA-PK and HA95.

Authors:  I Han; S Harada; D Weaver; Y Xue; W Lane; S Orstavik; B Skalhegg; E Kieff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.

Authors:  P Norio; C L Schildkraut; J L Yates
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  Immortalization of human primary B lymphocytes in vitro with DNA.

Authors:  B Kempkes; D Pich; R Zeidler; W Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.

Authors:  I K Ruf; A Moghaddam; F Wang; J Sample
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.